Skip to main content
. 2017 Jun 16;96(24):e7155. doi: 10.1097/MD.0000000000007155

Figure 1.

Figure 1

Selection of patients for study inclusion. MELD = model for end-stage liver disease, NOAC = novel oral anticoagulant, VKA = vitamin K antagonist.